Literature DB >> 8977755

Androgens and the menopause; a study of 40-60-year-old women.

J Bancroft1, E H Cawood.   

Abstract

OBJECTIVE: The impact of the menopause on androgen production is poorly understood. We have investigated the impact of the menopause, as well as other factors such as age, body mass index (BMI) and cigarette smoking, on ovarian and adrenal androgen levels in women aged 40-60 years.
DESIGN: Cross-sectional study of blood hormones sampled weekly over one month in volunteer 40-60-year-old women.
SUBJECTS: One hundred and forty-one women, aged between 40 and 60, recruited from community sources (non-clinical), not using hormone replacement or steroidal contraceptives, and with a current sexual partner. Fifty were categorized as premenopausal (ovulating), 37 as perimenopausal and 54 as post-menopausal. MEASUREMENTS: The following variables were assessed; menopausal status (based on menstrual history and pattern and plasma progesterone), age, BMI, smoking, oestradiol (E2), oestrone (E1), LH, FSH, total testosterone (TT), androstenedione (A), SHBG, free androgen index (FAI), dihydroepiandrosterone (DHEA), dihydroepiandrosterone sulphate (DHEAS) and cortisol.
RESULTS: are based on multiple regression analysis. TT was positively related to A, BMI and LH. A was negatively related to age and FSH, and positively to DHEA, DHEAS and premenopausal status. SHBG was negatively related to BMI and positively to E1 and non-smoking. DHEA and DHEAS were negatively related to age and were higher in smokers. Both E1 and E2 were related to menopausal status and to FSH. Surprisingly, E2 was negatively related to BMI.
CONCLUSIONS: A variety of factors influence androgen production in this age group. Whereas it is difficult to predict the effect of menopause on androgen levels, LH stimulation of post-menopausal interstitial cells, modulated by a variety of factors including nutrition, and smoking, are likely to be relevant.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8977755     DOI: 10.1046/j.1365-2265.1996.00846.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  15 in total

1.  Smoking as a determinant for plasma levels of testosterone, androstenedione, and DHEAs in postmenopausal women.

Authors:  Jonas Manjer; Robert Johansson; Per Lenner
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

2.  The association of plasma androgen levels with breast, ovarian and endometrial cancer risk factors among postmenopausal women.

Authors:  Kim N Danforth; A Heather Eliassen; Shelley S Tworoger; Stacey A Missmer; Robert L Barbieri; Bernard A Rosner; Graham A Colditz; Susan E Hankinson
Journal:  Int J Cancer       Date:  2010-01-01       Impact factor: 7.396

3.  Prenatal Exposure to Di(2-Ethylhexyl) Phthalate Causes Long-Term Transgenerational Effects on Female Reproduction in Mice.

Authors:  Emily Brehm; Saniya Rattan; Liying Gao; Jodi A Flaws
Journal:  Endocrinology       Date:  2018-02-01       Impact factor: 4.736

Review 4.  Hormonal aspects of sexual dysfunction: the therapeutic use of exogenous androgens in men and women.

Authors:  S N Seidman
Journal:  Curr Psychiatry Rep       Date:  2000-06       Impact factor: 5.285

5.  Cigarette smoking, androgen levels, and hot flushes in midlife women.

Authors:  Chrissy J Cochran; Lisa Gallicchio; Susan R Miller; Howard Zacur; Jodi A Flaws
Journal:  Obstet Gynecol       Date:  2008-11       Impact factor: 7.661

6.  Comparison of serum androgens and endometrial thickness in obese and non-obese postmenopausal women.

Authors:  Ilker İnan Arıkan; Aykut Barut; Deniz Arıkan; Müge Harma; Mehmet İbrahim Harma; Serpil Bozkurt
Journal:  J Turk Ger Gynecol Assoc       Date:  2010-09-01

7.  Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease.

Authors:  Glenn D Braunstein; B Delia Johnson; Frank Z Stanczyk; Vera Bittner; Sarah L Berga; Leslee Shaw; T Keta Hodgson; Maura Paul-Labrador; Ricardo Azziz; C Noel Bairey Merz
Journal:  J Clin Endocrinol Metab       Date:  2008-08-26       Impact factor: 5.958

8.  Testosterone, sex hormone-binding globulin and free androgen index among adult women: chronological and ovarian aging.

Authors:  M F R Sowers; H Zheng; D McConnell; B Nan; C A Karvonen-Gutierrez; J F Randolph
Journal:  Hum Reprod       Date:  2009-06-11       Impact factor: 6.918

9.  Association of depression, anxiety and menopausal-related symptoms with demographic, anthropometric and body composition indices in healthy postmenopausal women.

Authors:  Nasibeh Barghandan; Neda Dolatkhah; Fariba Eslamian; Nahal Ghafarifar; Maryam Hashemian
Journal:  BMC Womens Health       Date:  2021-05-07       Impact factor: 2.809

10.  A comprehensive analysis of the androgen receptor gene and risk of breast cancer: results from the National Cancer Institute Breast and Prostate Cancer Cohort Consortium (BPC3).

Authors:  David G Cox; Hélène Blanché; Celeste L Pearce; Eugenia E Calle; Graham A Colditz; Malcolm C Pike; Demetrius Albanes; Naomi E Allen; Pilar Amiano; Goran Berglund; Heiner Boeing; Julie Buring; Noel Burtt; Federico Canzian; Stephen Chanock; Françoise Clavel-Chapelon; Heather Spencer Feigelson; Matthew Freedman; Christopher A Haiman; Susan E Hankinson; Brian E Henderson; Robert Hoover; David J Hunter; Rudolf Kaaks; Laurence Kolonel; Peter Kraft; Loic LeMarchand; Eiliv Lund; Domenico Palli; Petra H M Peeters; Elio Riboli; Daniel O Stram; Michael Thun; Anne Tjonneland; Dimitrios Trichopoulos; Meredith Yeager
Journal:  Breast Cancer Res       Date:  2006       Impact factor: 6.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.